Intercept Pharmaceuticals reported $77.59M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acorda Therapeutics ACOR:US USD 31.47M 2.04M
Amarin AMRN:US USD 89.88M 4.56M
Amgen AMGN:US USD 6.84B 187M
Arrowhead Research ARWR:US USD 62.55M 30.97M
AstraZeneca AZN:LN USD 11.21B 225M
Biogen BIIB:US USD 2.54B 35.5M
Bluebird Bio BLUE:US USD 71K 1.45M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Eli Lilly And LLY:US USD 7.3B 360.2M
Esperion Therapeutics ESPR:US USD 18.82M 162K
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Neurocrine Biosciences NBIX:US USD 412M 24.1M
Novartis NOVN:VX USD 13B 159M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Sangamo Biosciences SGMO:US USD 27.23M 770K
Vertex Pharmaceuticals VRTX:US USD 2.3B 31.6M
YTE INCY:US USD 926.7M 103.4M